Omnichannel Engagement in Medical Affairs: Activities & Resources

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Omnichannel Engagement in Medical Affairs: Activities and Resources”

STUDY OVERVIEW

As biopharma organizations have accelerated the adoption of digital solutions, Medical Affairs groups are adopting an omnichannel approach to engagement to deliver a consistent, personalized experience across channels. However, to ensure seamless stakeholder engagement, it is critical to effectively allocate resources to the right activities.

Best Practices, LLC conducted this benchmarking research to probe the advances in omnichannel engagement activities by Medical Affairs groups. This study probes and profiles how different organizations are implementing a variety of digital and in-person engagement activities, ever-changing staff roles, and growing and shrinking resources dedicated to omnichannel efforts.

KEY TOPICS

Key Omnichannel Activities
Omnichannel Staffing
Omnichannel Resource Allocation

KEY METRICS

How many full-time equivalents (FTEs) are dedicated to your omnichannel efforts?
What is the role of each Medical sub-group in omnichannel engagement?
How important is it to have members with specific backgrounds on the omnichannel engagement team?
How effective are benchmark Medical Affairs teams in executing each of the components of their omnichannel engagement plan?
Approximately what percentage of the total Medical Affairs budget is allocated to omnichannel initiatives currently?
Approximately what percentage of the organization's total omnichannel engagement budget is allocated to each of the listed activity areas?
To what extent do specific listed factors influence the level of resources dedicated to omnichannel engagement for a program on a product-by-product basis?

SAMPLE KEY FINDINGS

Medical Strategy groups most often lead omnichannel programs: Strategy groups take a leading role at 100% of leading companies, followed by Medical Excellence (50%), and occasionally even Marketing. IT groups play a supporting role at 83% companies, followed by Medical Operations (59%), and Medical Information (56%).

METHODOLOGY

Best Practices, LLC engaged 57 leaders from 43 biopharma companies in this research through a benchmark survey.

Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Service; Chemical; Clinical Research; Laboratories

Companies Profiled:
AbbVie; Amgen; Apellis Pharmaceuticals; Astellas; AstraZeneca; Baxter International; Bayer; Biogen Idec; Boehringer Ingelheim; B. Braun; Cara Therapeutics; Chiesi; Cipla; Daiichi Sankyo; Eisai; Eli Lilly and Company; EVERSANA; Fidia; Genentech; General Electric; Gilead Sciences; GlaxoSmithKline ; Heron Therapeutics; Ipsen; Jazz Pharmaceuticals; Kyowa Kirin; Lupin; Lundbeck; Medexus Pharmaceuticals; Merck; Novartis; Novo Nordisk; Orchard Therapeutics; Pixacore; Provention Bio; Radius Health; Inc.; Roche; Sandoz; Sanofi; Santen; Supernus; Takeda Pharmaceuticals; Taysha Gene Therapies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Omnichannel Engagement in Medical Affairs: Activities and Resources

ID: 5748

Features:

Pages/Slides: 28

Published: 2023

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69AB9FFB1FB198DD30025893C003A858A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-omnichannel-engagement-in-medical-affairs-activities-resources?opendocument
18
19opendocument
2044.200.168.16
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB